Why Can’t You Give Meds Through an Arterial Line?

Arterial lines are used for continuous blood pressure monitoring and drawing blood samples, not for delivering medications, because drugs injected directly into an artery can cause devastating tissue damage, including gangrene and limb loss. The core problem is that an artery carries blood away from the heart and directly into tissues at high pressure, so a drug that would be harmlessly diluted and filtered through the venous system instead arrives at dangerously high concentrations in the small vessels of a hand, foot, or organ. Reports of this kind of injury go back to the 1940s, and the consequences documented since then are severe enough that the prohibition is one of the most firmly held safety rules in clinical practice.

How Arterial Blood Flow Turns a Routine Drug Into a Threat

When you receive a medication through a standard intravenous (IV) line, the drug enters a vein and travels toward the heart. Along the way it mixes with returning blood from the entire body, gets diluted substantially, passes through the right side of the heart, and then flows through the vast capillary network of the lungs before reaching the arterial side. By the time the drug reaches any single organ or limb, its concentration is a fraction of what was originally injected. The lungs also act as a physical filter. Research on intravenously delivered cells, for instance, has shown that the majority of larger particles get trapped in pulmonary capillaries and never make it through to the arterial circulation at all.¹ Drugs benefit from the same dilution and filtration process.

An artery, by contrast, carries oxygenated blood away from the heart and directly into the tissues it supplies. If a drug is pushed into the radial artery in your wrist, for example, it flows straight into the small arteries and capillaries of your hand and fingers at high concentration. The drug has not been diluted by the full volume of circulating blood. It has not passed through the lung’s capillary bed. It arrives essentially undiluted at the tissues downstream. Studies on selective arterial catheter injections have confirmed that pushing fluid into an artery produces substantial increases in both flow and pressure within that vessel for the duration of the injection.² That pressure spike forces the concentrated drug deep into tissue beds that were never meant to handle it.

This combination of high local concentration, high pressure, and direct delivery to end-organ capillaries is what makes arterial injection so dangerous. Many drugs are formulated at a pH or with additives that are irritating or toxic to the delicate endothelial lining of small blood vessels. When delivered intravenously, the dilution effect keeps concentrations below the damage threshold. When delivered arterially, those same drugs arrive at concentrations high enough to injure vessel walls, trigger intense spasm of the artery, cause clotting inside small vessels, and ultimately cut off blood supply to the tissue downstream.

The Cascade of Damage After Intra-Arterial Injection

The injury that follows accidental intra-arterial drug delivery tends to follow a recognizable pattern. First, the drug irritates or directly damages the endothelium, the thin inner lining of blood vessels. This damage triggers the artery to go into spasm, squeezing down and restricting blood flow. At the same time, the injury to the vessel wall activates the clotting cascade, leading to thrombus formation inside the small arteries and arterioles. Some drugs, particularly those formulated as suspensions or with crystalline particles, can physically occlude tiny vessels even without triggering a clot.

The result is ischemia: the tissue downstream is starved of oxygen. Depending on how much drug was injected, how toxic it is to vessels, and how long the ischemia goes unrecognized, the outcome ranges from temporary pain and numbness to full-thickness tissue death. A comprehensive review in the Mayo Clinic Proceedings documented that unintentional intra-arterial injection has led to paresthesias, severe pain, motor dysfunction, compartment syndrome, gangrene, and limb loss.³ A separate narrative review confirmed that while some drugs have been injected into arteries without major consequences, a number of agents are consistently associated with severe morbidity, including amputation.⁴

Which Drugs Are Most Dangerous

Not every medication is equally harmful if it ends up in an artery, but the list of high-risk agents is long and includes some commonly used drugs. The Mayo Clinic Proceedings review catalogued the reported complications by drug class:

Benzodiazepines (diazepam, temazepam, and others) have caused vascular impairment, arterial and venous thrombosis, compartment syndrome, rhabdomyolysis, and gangrene.
Barbiturates (thiopental, secobarbital, pentobarbital, and others) are frequently linked to severe tissue necrosis and gangrene.
Phenothiazines (promethazine, chlorpromazine) carry a similar profile of severe necrosis and gangrene.
Other agents including phenytoin, parenteral nutrition solutions, and certain antibiotics have caused complications ranging from digital artery occlusion to spinal artery thromboembolism.

Promethazine deserves special mention because it remains widely used in emergency departments and surgical settings, and the documented outcomes are particularly grim. For decades, injectable promethazine has been associated with rare but serious limb-threatening effects after extravasation or inadvertent intra-arterial injection.⁵ Case reports have described promethazine injections leading to necrosis and gangrene of the hand and fingers, with some patients ultimately requiring amputation.⁶ One case report documented digital gangrene after an inadvertent intra-arterial cocktail injection of pentazocine, promethazine, and atropine into what appeared to be the radial artery, affecting the lateral three digits and the dorsum of the hand.⁷

The common thread among the worst offenders is that they tend to be highly alkaline or acidic, formulated with irritating solvents, or contain particles that can physically block tiny vessels. Thiopental, for instance, is very alkaline. Diazepam is formulated with propylene glycol, which is toxic to endothelium in high concentrations. Promethazine has a pH low enough to cause chemical injury on contact with arterial endothelium. These properties are manageable when the drug passes through the venous system and is diluted before reaching sensitive tissues. In an artery, the chemistry hits delicate capillary beds at full strength.

How Accidental Arterial Injections Happen

You might assume this kind of mistake is vanishingly rare in professional settings, but the anatomy of the human arm, wrist, and foot makes it easier than you’d think. The radial artery sits close to commonly used veins at the wrist. In the antecubital fossa (the crease of your elbow), the brachial artery runs near the veins that are standard targets for IV access. In infants and small children, the arteries and veins in the dorsum of the hand and foot are especially close together, and the arteries in newborns can be quite small and easy to confuse with veins.

A case series from a children’s hospital reviewed over 18,000 incident reports and identified 10 cases of accidental intra-arterial medication administration, in patients ranging from 27 days to 13 years old. The most common accidental arterial cannulation sites were the dorsum of the foot and dorsum of the hand. The drugs accidentally injected included narcotics, sedatives, muscle relaxants, antibiotics, and crystalloid fluids. In some of these cases, the accidental arterial placement was not discovered immediately, with delays ranging from less than an hour to as long as 26 days. Seven of the ten patients had difficult IV access, and in two of those, ultrasound guidance had even been used.⁸

The finding that difficult IV access is a major risk factor makes intuitive sense. When a nurse or technician struggles to find a good vein, there are more needle sticks, more probing, and a higher chance of inadvertently landing in an artery instead. Pulsatile, bright-red blood return is the classic sign of arterial placement, but in hypotensive or hypothermic patients, arterial blood pressure can be low enough that pulsation is subtle and the blood color difference is hard to distinguish under fluorescent lighting.

Outside of hospitals, accidental intra-arterial injection is also a well-known complication of intravenous drug use. People injecting drugs into their own veins may hit an artery, particularly in the groin where the femoral artery and vein run side by side. Case series have documented severe vascular damage, ischemia, gangrene, and amputation from this route as well.⁹ The risk is compounded when the injected substance is a crushed oral tablet suspended in water, because the undissolved particles can physically obstruct small vessels.

What Happens When Treatment Is Delayed

Speed matters enormously after an accidental intra-arterial injection. A systematic review of inadvertent intra-arterial drug injections in the upper extremity found that patients who did not present for treatment until 14 hours or more after the injection had significantly higher rates of amputation. The same review found that patients injecting crushed pills rather than pharmaceutical-grade liquids also faced higher amputation rates, likely because of the added mechanical obstruction from particulate matter.¹⁰

When the problem is caught quickly, treatment typically involves several immediate steps. Anticoagulants, particularly heparin, were the most commonly used treatment in the systematic review, appearing in about three-quarters of cases. The goal is to prevent further clot formation in the damaged vessels. Steroids were associated with a lower incidence of amputation, likely by reducing the inflammatory response and arterial spasm. When secondary infection developed, the need for antibiotics was associated with worse outcomes, probably because infection on top of ischemic tissue signals a more advanced injury rather than because the antibiotics themselves were harmful.¹⁰

Other treatments that have been used include local injection of vasodilators (to relieve arterial spasm), sympathetic nerve blocks (to open up collateral blood flow), and in some cases surgical thrombectomy or fasciotomy for compartment syndrome. There is no single standardized protocol that all hospitals follow, which reflects both the rarity of the event and the variability in how different drugs cause injury.

When Doctors Do Inject Drugs Into Arteries on Purpose

The prohibition on arterial medication delivery has an important exception: in specialized interventional procedures, doctors deliberately inject certain drugs into arteries under highly controlled conditions. The key difference is that these procedures use specific drugs chosen for their safety in arteries, deliver them through catheters placed under real-time imaging guidance, and target the drug to a specific organ or tumor rather than sending it through an extremity’s end vessels.

One of the best-known examples is intra-arterial chemotherapy for liver cancer. By threading a catheter into the hepatic artery that feeds a tumor, interventionalists can deliver chemotherapy at high local concentrations while keeping systemic exposure low. Research on intra-arterial delivery of gemcitabine for pancreatic cancer, for instance, found that systemic plasma concentrations were dramatically lower when the drug was given via the arterial route compared to standard IV infusion, meaning less drug reaching the rest of the body and causing side effects.¹¹ Similarly, animal studies of intra-arterial hepatic oxaliplatin showed a significant pharmacokinetic advantage over IV administration, with higher drug concentrations in target tissue and lower systemic levels.¹² Intra-arterial delivery has also been explored for brain tumors, where the blood-brain barrier makes it difficult to get adequate drug concentrations via the IV route.¹³

Intra-arterial drug delivery also plays a role in treating stroke and brain vessel spasm. When a patient develops vasospasm after a brain aneurysm rupture, interventional neuroradiologists can thread a catheter into the affected brain artery and infuse vasodilators directly at the site of the spasm. A meta-analysis of 55 studies found that about nine out of ten patients showed an immediate improvement in the vessel on angiography, and roughly six in ten showed neurological improvement.¹⁴ For acute ischemic stroke, intra-arterial thrombolysis (injecting clot-dissolving drugs directly at the blockage site after mechanical clot retrieval) has shown improved rates of excellent functional recovery in multiple randomized trials, without a significant increase in bleeding complications.¹⁵¹⁶

These intentional applications highlight that the problem is not that arteries are inherently unable to handle any drug. The problem is the uncontrolled delivery of drugs that were not designed for arterial contact, at concentrations that damage small vessels, into vascular beds that terminate in fragile end-organ capillaries. Interventional procedures circumvent these risks by selecting appropriate drugs, controlling the dose precisely, and delivering them under direct visualization to vessels large enough to tolerate them.

Arterial Lines Are Not Built for Drug Delivery

Beyond the pharmacological hazards, there are practical engineering reasons that arterial lines are unsuitable for medication administration. Arterial lines are typically placed in the radial artery at the wrist or, less commonly, in the femoral or dorsalis pedis artery. They are connected to pressurized transducer systems that continuously measure blood pressure by sensing the pulsatile waveform. These systems run a slow flush of heparinized saline (usually around 3 mL per hour) to keep the catheter from clotting off, and any injection port on the line is there for blood sampling or zeroing the transducer, not for drug delivery.

The entire arterial line setup is color-coded (usually red) and labeled specifically to prevent confusion with IV lines. Luer-lock connections on arterial lines are sometimes deliberately incompatible with standard IV syringes as an added safety barrier. Hospitals have invested in these physical safeguards precisely because the consequences of accidental arterial injection are so dire and because human error under pressure is inevitable. A nurse managing multiple drips and lines on a critically ill patient at three in the morning needs every possible engineering barrier to prevent the wrong connection.

There is also the question of what would happen to the monitoring itself. The pressure waveform that an arterial line provides is a critical vital sign in intensive care. Injecting a drug bolus through the line would distort the waveform, making the blood pressure reading unreliable for some period. It would also risk introducing air bubbles, which in an artery travel forward into the small vessels of the hand or brain rather than being filtered out by the lungs as they would in the venous system. An arterial air embolism is a far more serious event than a venous one.

Contrast Dye and the Kidney Question

One interesting wrinkle in the arterial versus venous drug delivery story involves contrast dye used in medical imaging. Contrast agents are among the few substances routinely given through both veins (for CT scans) and arteries (during cardiac catheterization and angiography). This provides a natural comparison of the two routes. A randomized trial comparing CT angiography (IV contrast) with cardiac catheterization (intra-arterial contrast) in patients suspected of having coronary artery disease found that acute kidney injury occurred in about 6% of patients receiving IV contrast compared to about 13% of those receiving intra-arterial contrast, representing roughly a two-and-a-half-fold increased risk with the arterial route.¹⁷

This finding is striking because contrast dye is specifically formulated to be as safe as possible in both arteries and veins, and the kidney damage was still more common with the arterial route. The likely explanation loops back to the same principle: intra-arterial delivery sends a concentrated bolus of contrast directly to the kidneys via the aorta, whereas IV contrast is diluted by the full cardiac output before reaching the renal arteries. If even purpose-built, carefully optimized contrast dye causes more organ damage when given arterially, the case for keeping standard medications away from arteries is that much stronger.

Why the Safety Culture Around Arterial Lines Is So Strict

In most areas of medicine, safety rules exist on a spectrum. Some guidelines are followed loosely; others are followed with absolute rigidity. The prohibition on giving drugs through arterial lines falls firmly in the absolute category, and the reason is the asymmetry between the ease of the mistake and the severity of the outcome. Accidentally pushing a drug through the wrong line takes seconds. The result can be permanent loss of a hand. Case reports of these injuries have been published consistently for more than 80 years.³

Modern hospitals layer multiple safeguards against this: red color coding on arterial line tubing, explicit labels at every connection point, incompatible connector designs, staff education during orientation, and protocols requiring confirmation of line type before any injection. Some institutions have moved to needleless systems that make it physically impossible to attach a standard medication syringe to an arterial transducer setup. These measures reflect decades of accumulated case reports showing what happens when the barrier fails, and they explain why an ICU nurse will react with alarm if they see anyone reach for an arterial line port with a medication syringe in hand.